Two studies conducted by researchers from the Systemic Vasculitis IDIBAPS group (in the Autoimmune Diseases team), headed by Dr. Maria Cinta Cid, deepen in the mechanisms to block the inflammatory response in chronic inflammatory diseases such as giant cell arteritis (GCA). The first article, published in the Annals of the Rheumatic Diseases, explores the role of interferon gamma (an inflammatory protein) in GCA and its potential as a therapeutic target. In the second article, published in the Science Signaling journal, scientists have discovered a new function of one of the subunits that form the IL-23 protein that may be relevant in several chronic inflammatory diseases.
IDIBAPS researchers decipher mechanisms to understand the progression of chronic inflammatory diseases
Dr. Eduard Vieta, head of the Psychiatry and Psychology Department at Hospital Clínic and head of the IDIBAPS research group Biological bases of psychiatric disorders and nuclear psychiatry, received on June 17th an honorary doctorate by the University of Valencia (UV), in a solemn session in the Auditorium of the educational institution. The session was attended by the secretaries from the Generalitat Valenciana Josep Joan Vidal (Education) and Ricardo Campos (Public Health), as well as a broad representation of the university community.
Dr. Rafael Penadés, psychologist from the Schizophrenia Unit at Hospital Clínic and researcher at the IDIBAPS team Biological bases of psychiatric disorders and nuclear psychiatry and CIBERSAM, has been awarded with a grant from the Brain and Behavior Research Foundation within its program NARSAD Independent Investigator Grants. This foundation is one the largest private foundations in the United States dedicated to the research promotion in brain diseases such as sclerosis, epilepsy, Alzheimer’s disease, Parkinson’s disease, depression and schizophrenia.
Andreu Mas-Colell encourages researchers from IDIBAPS to apply for a grant from the European Research Council
Professor at the University Pompeu Fabra (UPF), Andreu Mas-Colell, encourages researchers from IDIBAPS to “apply for an European Research Council (ERC) grant given the high scientific level in this institution”. Professor Mas-Colell made these remarks during the inaugural conference of the celebrations of the 20th anniversary of IDIBAPS on Monday 30th May.
Dr. Elías Campo, Research Director at Hospital Clínic, head of the Human and experimental functional oncomorphology team at IDIBAPS and Chair at the Faculty of Medicine and Health Sciences of the University of Barcelona (UB), has been awarded with the “Rey Jaime I” award in the “medical research” category. Last Tuesday the list of winners of the 2016 edition of the awards was announced in an official ceremony held at the Palace of the Generalitat Valenciana, with the presence of the board chairman, Ximo Puig; the president of the Valencian Foundation for Advanced Studies and Vice President of the Rey Jaime I” Awards Foundation, Vicente Boluda, and the Permanent Secretary of the “Rey Jaime I” Awards, Santiago Grisolía.
Published today in JAMA Oncology, Principal Investigator of Vall d´Hebron Institute of Oncology´s (VHIO) Translational Genomics Group, and now Team Leader of translational genomics and targeted therapeutics in solid tumors at the August Pi I Sunyer Biomedical Research Institute (IDIBAPS), and Head of Medical Oncology at the Hospital Clínic in Barcelona, Aleix Prat, has led a study showing the intrinsic subtyping of breast cancer by means of a genomic test as the most important prognostic factor in advanced or metastatic hormone-sensitive breast cancer. Findings show that the genomic classification of tumors — the molecular subtyping of primary tumors, can predict the evolution of patients from the onset of metastasis and that this cancer intrinsic classification can better guide treatment decisions in the first-line metastatic setting. Read the rest of this entry »